How to buy Phreesia stock

Phreesia, Inc is a health information services business based in the US. Phreesia shares (PHR) are listed on the NYSE and all prices are listed in US Dollars. Phreesia employs 827 staff and has a trailing 12-month revenue of around 0.00.

Phreesia share price

Use our graph to track the performance of PHR stocks over time.

Phreesia shares at a glance

• Key figures

Information last updated 2021-04-21.

52-week range	$23.54 - $81.59
50-day moving average	$54.73
200-day moving average	$52.99
Wall St. target price	$64.83
PE ratio	2.9116
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-35.45

Buy Phreesia shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Phreesia stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Phreesia, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Phreesia under- or over-valued?

Valuing Phreesia stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Phreesia's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Phreesia's P/E ratio

Phreesia's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 3x. In other words, Phreesia shares trade at around 3x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Phreesia financials

Revenue TTM	$148.7 million
Gross profit TTM	$96.3 million
Return on assets TTM	-6.52%
Return on equity TTM	-14.95%
Profit margin	-18.36%
Book value	$5.88
Market capitalisation	$2.5 billion

TTM: trailing 12 months

Shorting Phreesia shares

There are currently 1.5 million Phreesia shares held short by investors – that's known as Phreesia's "short interest". This figure is 11.3% up from 1.3 million last month.

There are a few different ways that this level of interest in shorting Phreesia shares can be evaluated.

Phreesia's "short interest ratio" (SIR)

Phreesia's "short interest ratio" (SIR) is the quantity of Phreesia shares currently shorted divided by the average quantity of Phreesia shares traded daily (recently around 437814.75903614). Phreesia's SIR currently stands at 3.32. In other words for every 100,000 Phreesia shares traded daily on the market, roughly 3320 shares are currently held short.

However Phreesia's short interest can also be evaluated against the total number of Phreesia shares, or, against the total number of tradable Phreesia shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Phreesia's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Phreesia shares in existence, roughly 30 shares are currently held short) or 0.0406% of the tradable shares (for every 100,000 tradable Phreesia shares, roughly 41 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Phreesia.

Find out more about how you can short Phreesia stock.

Phreesia share dividends

We're not expecting Phreesia to pay a dividend over the next 12 months.

Phreesia overview

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a Web-based dashboard for providers; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; appointments solution for online appointments, reminders, and referral tracking; and patient activation solution that enables providers to communicate with their patients through surveys, announcements, messaging, and health campaigns. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and PRO data for approximately 25 specialties; and life sciences solution to deliver targeted and clinically relevant marketing content to patients, as well as COVID-19 product offerings for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies.

Frequently asked questions

• What percentage of Phreesia is owned by insiders or institutions?

  Currently 5.751% of Phreesia shares are held by insiders and 100.164% by institutions.

• How many people work for Phreesia?

  Latest data suggests 827 work at Phreesia.

• When does the fiscal year end for Phreesia?

  Phreesia's fiscal year ends in January.

• Where is Phreesia based?

  Phreesia's address is: 434 Fayetteville St, Raleigh, NC, United States, 27601

• What is Phreesia's ISIN number?

  Phreesia's international securities identification number is: US71944F1066

• What is Phreesia's CUSIP number?

  Phreesia's Committee on Uniform Securities Identification Procedures number is: 71944F106